Evommune, Inc. (EVMN) Institutional Ownership Changes & 13F Activity
Evommune, Inc. (EVMN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Mpm Bioimpact Llc, Janus Henderson Group Plc, Baker Bros. Advisors Lp, Alyeska Investment Group, L.P., and Perceptive Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Wells Fargo & Company/Mn | Buy | +3,867 | — | 3,867 | $88.90K | Q1 2026 | Jul 08, 2026 |
| Bank Of America Corp | Buy | +27,264 | +928.3% | 30,201 | $694.32K | Q1 2026 | May 18, 2026 |
| California State Teachers Retirement System | Buy | +571 | — | 571 | $13.13K | Q1 2026 | May 18, 2026 |
| Mpm Bioimpact Llc | Buy | +1,342,841 | +1188.1% | 1,455,863 | $33.47M | Q1 2026 | May 15, 2026 |
| Janus Henderson Group Plc | Buy | +896,700 | — | 896,700 | $20.62M | Q1 2026 | May 15, 2026 |
| Baker Bros. Advisors Lp | Buy | +847,390 | — | 847,390 | $19.48M | Q1 2026 | May 15, 2026 |
| Alyeska Investment Group, L.P. | Buy | +726,362 | — | 726,362 | $16.70M | Q1 2026 | May 15, 2026 |
| Perceptive Advisors Llc | Buy | +448,350 | — | 448,350 | $10.31M | Q1 2026 | May 15, 2026 |
| Kynam Capital Management, Lp | Buy | +440,014 | +237.2% | 625,496 | $14.38M | Q1 2026 | May 15, 2026 |
| Octagon Capital Advisors Lp | Sell | -356,528 | -71.3% | 143,472 | $3.30M | Q1 2026 | May 15, 2026 |
| Freestone Grove Partners Lp | Buy | +337,291 | — | 337,291 | $7.75M | Q1 2026 | May 15, 2026 |
| Price T Rowe Associates Inc | Buy | +336,900 | +43.1% | 1,119,021 | $25.73M | Q1 2026 | May 15, 2026 |
| Eventide Asset Management, Llc | Buy | +247,604 | +25.8% | 1,209,129 | $27.80M | Q1 2026 | May 15, 2026 |
| Rtw Investments, Lp | Buy | +218,564 | +17.0% | 1,502,235 | $34.54M | Q1 2026 | May 15, 2026 |
| State Street Corp | Buy | +148,011 | +469.9% | 179,511 | $4.13M | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +138,830 | +126.5% | 248,611 | $5.72M | Q1 2026 | May 15, 2026 |
| Stempoint Capital Lp | Buy | +125,581 | +184.1% | 193,777 | $4.39M | Q1 2026 | May 15, 2026 |
| Marshall Wace, Llp | Sell | -108,472 | -11.0% | 879,728 | $20.22M | Q1 2026 | May 15, 2026 |
| Integral Health Asset Management, Llc | Buy | +100,000 | +80.0% | 225,000 | $5.17M | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Buy | +92,648 | +150.2% | 154,323 | $3.55M | Q1 2026 | May 15, 2026 |
| Sphera Funds Management Ltd. | Sell | -87,913 | -52.9% | 78,234 | $1.80M | Q1 2026 | May 15, 2026 |
| American Century Companies Inc | Buy | +75,483 | +18.1% | 492,938 | $11.33M | Q1 2026 | May 15, 2026 |
| Velan Capital Investment Management Lp | Sell | -60,499 | -11.9% | 446,255 | $10.26M | Q1 2026 | May 15, 2026 |
| Eversept Partners, Lp | Buy | +54,680 | — | 54,680 | $1.26M | Q1 2026 | May 15, 2026 |
| Ra Capital Management, L.P. | Buy | +35,868 | +1.0% | 3,494,638 | $80.34M | Q1 2026 | May 15, 2026 |
| Charles Schwab Investment Management Inc | Buy | +32,244 | +51.4% | 94,948 | $2.18M | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +16,724 | +200.4% | 25,070 | $576.36K | Q1 2026 | May 15, 2026 |
| Verition Fund Management Llc | Sell | -15,223 | -2.7% | 549,991 | $12.64M | Q1 2026 | May 15, 2026 |
| Xtx Topco Ltd | Sell | -6,738 | -35.9% | 12,040 | $276.80K | Q1 2026 | May 15, 2026 |
| Mirae Asset Global Etfs Holdings Ltd. | Buy | +4,881 | — | 4,881 | $112.21K | Q1 2026 | May 15, 2026 |
Frequently asked questions about EVMN activity
Which institutional owners are buying EVMN?
Institutional owners buying EVMN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in EVMN activity?
"Buy" means an investor increased their reported position in EVMN compared to the prior reporting period. This reflects growing exposure to Evommune, Inc. (EVMN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in EVMN increasing?
Institutional interest in EVMN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related EVMN Institutional Insights
- EVMN Overview
- EVMN 13F Institutional Holders
- EVMN Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- EVMN Insider Trading & SEC Form 4 Activity
- EVMN Articles
- Top Institutional Investor Stock Rankings